This inventor holds 11 USPTO granted patents. Top assignees: Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh, Biopharm Gesellschaft Zur Biotechnologischen Entwicklung, Biopharm Gesellschaft Zur Biotechnologischen. Active years: 1998-2010.
Location History:
- Birkenweg, DE (2006)
- Marburg, DE (1998 - 2010)
Company Filing History:
7 out of 24 
2 out of 2 
1 out of 1 Years Active: 1998-2010
Title: Helge Neidhardt: Innovator in TGF-β Protein Research
Introduction
Helge Neidhardt is a prominent inventor based in Marburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of growth and differentiation factors. With a total of 11 patents to his name, Neidhardt's work has had a substantial impact on medical applications.
Latest Patents
Neidhardt's latest patents focus on the TGF-β family of proteins. One of his inventions concerns a protein of the TGF-β family, along with the DNA coding for it and a pharmaceutical composition containing the protein. Another patent provides DNA sequences encoding novel members of the TGF-β family. These proteins function as growth and differentiation factors, which are useful in various medical applications. His inventions also describe the isolation of these DNA sequences, the expression of the encoded proteins, and the production of pharmaceutical compositions containing these proteins.
Career Highlights
Throughout his career, Helge Neidhardt has worked with notable companies in the biotechnology sector. He has been associated with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH and Biopharm Gesellschaft zur Biotechnologischen Entwicklung. His work in these organizations has contributed to advancements in pharmaceutical development.
Collaborations
Neidhardt has collaborated with several professionals in his field, including Rolf Bechtold and Jens Pohl. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Helge Neidhardt is a distinguished inventor whose work in the TGF-β protein research has led to significant advancements in biotechnology. His contributions continue to influence medical applications and the development of pharmaceutical compositions.